Division of Surgery & Interventional Science, University College London (UCL), London, UK.
Plastic and Reconstructive Surgery Department, NHS Foundation Trust Hospital, Royal Free London, Pond Street, London, UK.
J Nanobiotechnology. 2019 Apr 6;17(1):51. doi: 10.1186/s12951-019-0477-z.
Children born with a small or absent ear undergo surgical reconstruction to create a suitable replacement using rib cartilage. To overcome the donor site morbidity and long-term pain of harvesting rib cartilage, synthetic materials can be a useful alternative. Medpor, is the currently used synthetic polyethylene material to replace missing facial cartilage but unfortunately it has high levels of surgical complications including infection and extrusion, making it an unsuitable replacement. New materials for facial cartilage reconstruction are required to improve the outcomes of surgical reconstruction. This study has developed a new nanomaterial with argon surface modification for auricular cartilage replacement to overcome the complications with Medpor.
Polyurethanes nanocomposites scaffolds (PU) were modified with argon plasma surface modification (Ar) and compared to Medpor in vitro and in vivo. Ar scaffolds allowed for greater protein adsorption than Medpor and PU after 48 h (p < 0.05). Cell viability and DNA assays demonstrated over 14-days greater human dermal fibroblast adhesion and cell growth on Ar than PU and Medpor nanocomposites scaffolds (p < 0.05). Gene expression using RT-qPCR of collagen-I, fibronectin, elastin, and laminin was upregulated on Ar scaffolds compared to Medpor and PU after 14-days (p < 0.05). Medpor, unmodified polyurethane and plasma modified polyurethane scaffolds were subcutaneously implanted in the dorsum of mice for 12 weeks to assess tissue integration and angiogenesis. Subcutaneous implantation of Ar scaffolds in mice dorsum, demonstrated significantly greater tissue integration by H&E and Massons trichrome staining, as well as angiogenesis by CD31 vessel immunohistochemistry staining over 12-weeks (p < 0.05).
Argon modified polyurethane nanocomposite scaffolds support cell attachment and growth, tissue integration and angiogenesis and are a promising alternative for facial cartilage replacement. This study demonstrates polyurethane nanocomposite scaffolds with argon surface modification are a promising biomaterial for cartilage tissue engineering applications.
患有小耳或无耳的儿童需要接受手术重建,使用肋软骨来创造合适的替代品。为了克服肋软骨采集的供区发病率和长期疼痛,合成材料可以作为一种有用的替代品。Medpor 是目前用于替代缺失的面部软骨的合成聚乙烯材料,但不幸的是,它的手术并发症发生率很高,包括感染和挤出,使其成为一种不合适的替代品。需要新的材料来改善面部软骨重建的手术效果。本研究开发了一种具有氩气表面改性的新型纳米材料,用于替代耳廓软骨,以克服 Medpor 的并发症。
聚氨基甲酸酯纳米复合材料支架(PU)经过氩等离子体表面改性(Ar)处理,并与 Medpor 进行了体外和体内比较。Ar 支架在 48 小时后允许比 Medpor 和 PU 吸附更多的蛋白质(p<0.05)。细胞活力和 DNA 测定表明,在 Ar 纳米复合材料支架上,人真皮成纤维细胞的粘附和细胞生长超过 14 天(p<0.05)。在 14 天的时间里,与 Medpor 和 PU 相比,Ar 支架上的胶原蛋白-I、纤维连接蛋白、弹性蛋白和层粘连蛋白的基因表达上调(p<0.05)。未经修饰的聚氨基甲酸酯和等离子体改性的聚氨基甲酸酯支架在小鼠背部皮下植入 12 周,以评估组织整合和血管生成。在 12 周的时间里,Ar 支架在小鼠背部的皮下植入,通过 H&E 和 Massons 三色染色以及 CD31 血管免疫组织化学染色显示出明显更好的组织整合和血管生成(p<0.05)。
氩改性的聚氨基甲酸酯纳米复合材料支架支持细胞附着和生长、组织整合和血管生成,是替代面部软骨的有前途的选择。本研究表明,经过氩表面改性的聚氨基甲酸酯纳米复合材料支架是软骨组织工程应用的一种有前途的生物材料。